Skip to main content
MBRX
NASDAQ Life Sciences

Moleculin Biotech Raises $2.7M from Warrant Exercises, Updates Outstanding Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$3.54
Mkt Cap
$19.051M
52W Low
$1.79
52W High
$24
52W Position info
98% above low
Off High info
85% below high
Rel. Volume info
4.6× avg
Market data snapshot near publication time

MBRX sits 98% above its 52-week low of $1.79 on elevated volume (4.6× avg).

Summary

Moleculin Biotech secured $2.7 million from warrant exercises, providing critical capital to address its previously disclosed 'going concern' warning, though it resulted in significant share dilution.


Key Events · Financing and Capital Events · MBRX

  • Warrant Exercises Generate $2.7 Million

    The company received approximately $2.7 million in gross proceeds from the exercise of 1,361,500 warrants.

  • Updated Share Count

    As of June 29, 2026, the total outstanding common stock increased to 7,065,000 shares.

  • Addresses Capital Needs

    This capital infusion helps address the company's previously disclosed 'going concern' warning and need for $25 million in new capital, despite the significant dilution.


Analysis · MBRX · Life Sciences

This filing reports the exercise of warrants generating $2.7 million in gross proceeds, a substantial capital infusion for a company with a $19 million market cap. While highly dilutive, this cash is crucial for Moleculin Biotech, which previously issued a 'going concern' warning and indicated a need for $25 million in new capital. The proceeds help extend the company's financial runway. The filing also updates the total outstanding shares to 7,065,000 as of June 29, 2026.

How filings like this one have moved

In the 30 days to Nov 4, 2026, 41.4% of the 1217 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MBRX was trading at $3.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $19.1M. The 52-week trading range was $1.79 to $24.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MBRX - Latest Insights

MBRX
Oct 30, 2026, 8:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.70
Real-time Price: $8.30 info
Change: -$0.400 (-5%) info
Market Cap: $8.715M info
MBRX
Oct 20, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.280
Real-time Price: $8.30 info
Change: Reverse Stock Split info
Market Cap: $8.715M info
MBRX
Oct 16, 2026, 9:29 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.310
Real-time Price: $8.30 info
Change: Reverse Stock Split info
Market Cap: $8.715M info
MBRX
Oct 16, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3617
Real-time Price: $8.30 info
Change: Reverse Stock Split info
Market Cap: $8.715M info
MBRX
Oct 09, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4469
Real-time Price: $8.30 info
Change: Reverse Stock Split info
Market Cap: $8.715M info